Chromatography process development in the quality by design paradigm I: Establishing a high‐throughput process development platform as a tool for estimating “characterization space” for an ion exchange chromatography step

This article describes the development of a high‐throughput process development (HTPD) platform for developing chromatography steps. An assessment of the platform as a tool for establishing the “characterization space” for an ion exchange chromatography step has been performed by using design of experiments. Case studies involving use of a biotech therapeutic, granulocyte colony‐stimulating factor have been used to demonstrate the performance of the platform. We discuss the various challenges that arise when working at such small volumes along with the solutions that we propose to alleviate these challenges to make the HTPD data suitable for empirical modeling. Further, we have also validated the scalability of this platform by comparing the results from the HTPD platform (2 and 6 μL resin volumes) against those obtained at the traditional laboratory scale (resin volume, 0.5 mL). We find that after integration of the proposed correction factors, the HTPD platform is capable of performing the process optimization studies at 170‐fold higher productivity. The platform is capable of providing semi‐quantitative assessment of the effects of the various input parameters under consideration. We think that platform such as the one presented is an excellent tool for examining the “characterization space” and reducing the extensive experimentation at the traditional lab scale that is otherwise required for establishing the “design space.” Thus, this platform will specifically aid in successful implementation of quality by design in biotech process development. This is especially significant in view of the constraints with respect to time and resources that the biopharma industry faces today. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 403–414, 2013

[1]  Steven Kozlowski,et al.  Considerations for Biotechnology Product Quality by Design , 2008 .

[2]  M. Hafner,et al.  Influence of protein and stationary phase properties on protein-matrix-interaction in cation exchange chromatography. , 2011, Journal of chromatography. A.

[3]  Beckley K. Nfor,et al.  High-throughput isotherm determination and thermodynamic modeling of protein adsorption on mixed mode adsorbents. , 2010, Journal of chromatography. A.

[4]  Jürgen Hubbuch,et al.  High Throughput Screening for the Design and Optimization of Chromatographic Processes: Automated Optimization of Chromatographic Phase Systems , 2009 .

[5]  Tryggve Bergander,et al.  High‐Throughput Process Development: Determination of Dynamic Binding Capacity Using Microtiter Filter Plates Filled with Chromatography Resin , 2008, Biotechnology progress.

[6]  A S Rathore,et al.  Use of computational fluid dynamics as a tool for establishing process design space for mixing in a bioreactor , 2012, Biotechnology progress.

[7]  Brian D. Kelley,et al.  High‐throughput screening of chromatographic separations: II. Hydrophobic interaction , 2008, Biotechnology and bioengineering.

[8]  K. J. Mukherjee,et al.  Overexpression and purification of recombinant human interferon alpha2b in Escherichia coli. , 2005, Protein expression and purification.

[9]  Anurag S Rathore,et al.  Roadmap for implementation of quality by design (QbD) for biotechnology products. , 2009, Trends in biotechnology.

[10]  Karol M Łącki,et al.  High-throughput process development of chromatography steps: advantages and limitations of different formats used. , 2012, Biotechnology journal.

[11]  Xiangyang Wang,et al.  Case Study on Definition of Process Design Space for a Microbial Fermentation Step , 2008 .

[12]  Xiangyang Wang,et al.  Defining Process Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation , 2008, Biotechnology progress.

[13]  Mark J. Bailey,et al.  A platform for high-throughput molecular characterization of recombinant monoclonal antibodies. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  Jürgen Hubbuch,et al.  High Throughput Screening for the Design and Optimization of Chromatographic Processes - Miniaturization, Automation and Parallelization of Breakthrough and Elution Studies , 2008 .

[15]  Kaushal Kumar,et al.  High-throughput process development for biopharmaceutical drug substances. , 2011, Trends in biotechnology.

[16]  Eric J. Suda,et al.  Comparison of agarose and dextran-grafted agarose strong ion exchangers for the separation of protein aggregates. , 2009, Journal of chromatography. A.

[17]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[18]  Jatinder Singh International conference on harmonization of technical requirements for registration of pharmaceuticals for human use , 2015, Journal of pharmacology & pharmacotherapeutics.

[19]  T. Ishihara,et al.  Optimization of monoclonal antibody purification by ion-exchange chromatography. Application of simple methods with linear gradient elution experimental data. , 2005, Journal of chromatography. A.

[20]  Sunil Chhatre,et al.  Review: Microscale methods for high‐throughput chromatography development in the pharmaceutical industry , 2009 .

[21]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[22]  J. King,et al.  Aggregation of granulocyte‐colony stimulating factor in vitro involves a conformationally altered monomeric state , 2005, Protein science : a publication of the Protein Society.

[23]  B. Kelley,et al.  High-throughput screening of chromatographic separations: I. Method development and column modeling. , 2008, Biotechnology and bioengineering.

[24]  K. Chittur,et al.  FTIR/ATR for protein adsorption to biomaterial surfaces. , 1998, Biomaterials.

[25]  Anurag Rathore,et al.  Use of the design‐of‐experiments approach for the development of a refolding technology for progenipoietin‐1, a recombinant human cytokine fusion protein from Escherichia coli inclusion bodies , 2009, Biotechnology and applied biochemistry.

[26]  P Dunnill,et al.  Micro biochemical engineering to accelerate the design of industrial‐scale downstream processes for biopharmaceutical proteins , 2008, Biotechnology and bioengineering.

[27]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[28]  Sanchayita Ghose,et al.  Defining process design space for a hydrophobic interaction chromatography (HIC) purification step: Application of quality by design (QbD) principles , 2010, Biotechnology and bioengineering.

[29]  Joe X. Zhou,et al.  pH-conductivity hybrid gradient cation-exchange chromatography for process-scale monoclonal antibody purification. , 2007, Journal of chromatography. A.

[30]  Jürgen Hubbuch,et al.  High‐throughput screening of packed‐bed chromatography coupled with SELDI‐TOF MS analysis: monoclonal antibodies versus host cell protein , 2007, Biotechnology and bioengineering.

[31]  G. Carta Predicting protein dynamic binding capacity from batch adsorption tests. , 2012, Biotechnology journal.

[32]  André Kiesewetter,et al.  Cation exchange chromatography in antibody purification: pH screening for optimised binding and HCP removal. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.